A detailed history of Montag A & Associates Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 12 shares of CRL stock, worth $2,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$2,013
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$145.57 - $178.99 $1,746 - $2,147
12 New
12 $1,000
Q1 2024

May 07, 2024

BUY
$203.52 - $273.43 $1.67 Million - $2.25 Million
8,221 New
8,221 $2.23 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.